Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$6.2MFederal grants as PI8 awards
0Patents grantedNone matched
159Papers10,808 citations
Federal awards and patents by year
AwardsPatents
8 awards · $6.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 28, 2026 | NIH | SBIR Phase II eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening | $824K | Eclipse Bioinnovations, Inc. |
| Jan 13, 2025 | NIH | SBIR Phase II eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening | $1.1M | Eclipse Bioinnovations, Inc. |
| Jun 7, 2024 | NIH | SBIR Phase II eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening | $296K | Eclipse Bioinnovations, Inc. |
| Sep 9, 2022 | NIH | SBIR Phase II Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | $862K | Eclipse Bioinnovations, Inc. |
| Sep 22, 2021 | NIH | SBIR Phase II Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide | $1.1M | Eclipse Bioinnovations, Inc. |
| Sep 17, 2019 | NIH | SBIR Phase I Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification | $350K | Eclipse Bioinnovations, Inc. |
| Aug 15, 2018 | NIH | SBIR Phase II A robust kit, standards, and software for identifying RNA binding protein targets | $305K | Eclipse Bioinnovations, Inc. |
| Sep 20, 2017 | NIH | SBIR Phase II A robust kit, standards, and software for identifying RNA binding protein targets | $1.3M | Eclipse Bioinnovations, Inc. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#173
Awards as PI#190
Patents#273
Companies
- Eclipse Bioinnovations, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.